Skip to main content
AVBP
NASDAQ Life Sciences

ArriVent BioPharma Narrows Q1 Net Loss to $43.3M, Advances Key Drug to Phase 3

Tom Rudovsky · Reported by Wiseek News
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
8
Price
$29.02
Mkt Cap
$1.346B
52W Low
$16.1
52W High
$32.14
52W Position info
80% above low
Off High info
9.7% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

AVBP sits 80% above its 52-week low of $16.1.

Summary

ArriVent BioPharma reported a Q1 2026 net loss of $(43.3M) and diluted loss per share of $(0.96). This represents a significant improvement from a net loss of $(64.4M) and EPS of $(1.90) in the prior year quarter, indicating a positive financial trend for the development-stage biotech. The company also highlighted substantial pipeline progress, including its lead candidate firmonertinib advancing into pivotal Phase 3 trials for EGFRm non-small cell lung cancer and positive interim Phase 1b data for ARR-217. These operational advancements, coupled with narrowing losses, are crucial for a biotechnology firm. Traders will monitor the continued progress of clinical trials and future financial reports for further catalysts.

At the time of this announcement, AVBP was trading at $29.02 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.3B. The 52-week trading range was $16.10 to $32.14. This news item was assessed with neutral market sentiment and an importance score of 8 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

AVBP - Latest Insights

AVBP
Nov 09, 2026, 4:21 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $14.16
Real-time Price: $11.26 info
Change: -$2.90 (-20%) info
Market Cap: $582.402M info
AVBP
Nov 09, 2026, 4:05 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $14.16
Real-time Price: $11.26 info
Change: -$2.90 (-20%) info
Market Cap: $582.402M info
AVBP
Nov 09, 2026, 4:01 PM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $14.16
Real-time Price: $11.26 info
Change: -$2.90 (-20%) info
Market Cap: $582.402M info
AVBP
Oct 26, 2026, 6:00 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $23.30
Real-time Price: $11.26 info
Change: -$12.04 (-52%) info
Market Cap: $582.402M info
AVBP
Oct 12, 2026, 5:29 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $16.46
Real-time Price: $11.26 info
Change: -$5.20 (-32%) info
Market Cap: $582.402M info